Cancer Genetics Inc
CGIX
Delayed Nasdaq - 12/13 03:53:08 pm
1.9USD
+2.7%
Upcoming events
12/14/17
Benchmark Company, LLC Micro Cap Discovery Conference
Past Events
12/05/17 | 06:00pmLD Micro Conference
11/09/17 | 02:30pmQ3 2017 Earnings Call
11/09/17Q3 2017 Earnings Release
10/19/17 | 05:00pmDawson James Securities Small Cap Growth Conference
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
27,0
26,9
0,55%

30,8
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-14,3
-14,5
1,0%

-7,55
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-16,7
-17,0
1,3%

-11,3
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-15,8
-17,1
7,3%

-17,5
Net income
Million $
Released
Forecast
Spread
-15,8
-17,1
7,3%

-16,8
EPS
 $
Released
Forecast
Spread
-1,00
-1,10
9,1%

-0,86
Announcement Date03/23/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
8,03
7,91
1,5%

9,27
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-2,67
-1,91
-39%

-1,74
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-3,19
-2,67
-20%

-2,46
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-0,63
-2,80
77%

-2,54
Net income
Million $
Released
Forecast
Spread
-0,63
-2,80
77%

-2,54
EPS
 $
Released
Forecast
Spread
-0,15
-0,12
-22%

-0,10
Announcement Date11/09/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise